KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Labcorp Holdings (LH) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Labcorp Holdings (LH) over the last 17 years, with Q3 2025 value amounting to 11.13%.

  • Labcorp Holdings' EBITDA Margin rose 33900.0% to 11.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.69%, marking a year-over-year increase of 38100.0%. This contributed to the annual value of 8.35% for FY2024, which is 23900.0% up from last year.
  • As of Q3 2025, Labcorp Holdings' EBITDA Margin stood at 11.13%, which was up 33900.0% from 11.18% recorded in Q2 2025.
  • In the past 5 years, Labcorp Holdings' EBITDA Margin registered a high of 48.51% during Q4 2021, and its lowest value of 4.05% during Q4 2023.
  • For the 5-year period, Labcorp Holdings' EBITDA Margin averaged around 12.99%, with its median value being 10.86% (2023).
  • In the last 5 years, Labcorp Holdings' EBITDA Margin surged by 322400bps in 2021 and then plummeted by -475400bps in 2022.
  • Over the past 5 years, Labcorp Holdings' EBITDA Margin (Quarter) stood at 48.51% in 2021, then crashed by -98bps to 0.97% in 2022, then plummeted by -516bps to 4.05% in 2023, then surged by 261bps to 6.5% in 2024, then surged by 71bps to 11.13% in 2025.
  • Its EBITDA Margin was 11.13% in Q3 2025, compared to 11.18% in Q2 2025 and 9.75% in Q1 2025.